Madagascar

in page functions
Total population (2013) 22,924,851
Birth cohort (2013) 796,849
Surviving Infants (surviving to 1 year per year, 2013) 768,306
Infant mortality rate (deaths < 1 year per 1000 births, 2012) 41/1000
Child mortality rate (deaths < 5 years per 1000 births, 2012) 58/1000
World Bank Index, IDA (2012) 3.36
Gross Nation Income (per capita US$, 2012) 430
Co-financing status (2013) Low-income
No. of districts/territories (2012) 112

GAVI support for Madagascar

Type of support

Approvals

2001-2017 (US$)
(31 Dec 2013)

Commitments

2001-2017 (US$)
(31 Dec 2013)

Disbursements

2000-2013 (US$)
(31 Dec 2013)

% Disbursed

(31 Dec 2013)
2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015
Cash Support $175,500 $177,500 $175,500 100%
Health system strengthening (HSS) $7,667,000 $11,216,500 $7,667,000 100%
HPV Demo (NVS) $259,749 $259,749 $249,302 96%
Immunisation services support (ISS) $4,064,400 $4,064,400 $4,064,400 100%
Injection safety support (INS) $615,555 $615,555 $615,555 100%
Penta (NVS) $37,977,458 $43,244,458 $35,971,643 95%
Pneumo (NVS) $40,625,749 $40,625,749 $34,250,458 84%
Rotavirus (NVS) $4,894,500 $4,894,500 $3,162,985 65%
Tetra DTP-HepB (NVS) $13,792,698 $13,792,698 $13,792,698 100%
Vaccine Introduction Grant $1,592,000 $1,592,000 $1,592,000 100%
Total $111,664,608 $120,483,108 $101,541,540

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the GAVI Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Madagascar DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2012)

Grade of confidence
86%

***
DTP3 - Official country estimates (2012) 86%
M:F sex ratio at birth (2013) 1.03
Household survey: DTP3 coverage for male (2009) 72.60%
Household survey: DTP3 coverage for female (2009) 73.00%
Household survey: Last DTP3 survey (2009) 73%
% districts achieving > 80% DTP3 coverage (2012) 68%
% districts achieving < 50% DTP3 coverage (2012) 1%
MCV WHO/UNICEF estimates (2012) 69%
Polio WHO/UNICEF estimates (2012) 86%

Breakdown of support

Non-vaccine support Vaccine support
14% 86%
$14,114,454 $87,427,084

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Madagascar

07 August 2013

Sabin Institute

At Dakar conference, countries showcase increased efforts to fund their own immunisation programs

Sabin Vaccine Institute convenes government officials to discuss progress on sustainable immunization financing programs (News release: Sabin Vaccine Institute).

25 July 2013

02-GAVI-11-Ed Harris-Madagascar

Research shows high impact of Hib vaccines in developing countries

Results of Hib Initiative supplement published showing new evidence on the impact of Hib vaccines

29 May 2013

WomenDeliverSeth.jpg

Vaccines against cervical cancer and rubella to benefit health of women and girls

Two new vaccines that help protect against cervical cancer, measles and rubella spearhead the GAVI Alliance’s commitment to improving the health of girls and women.

close icon

modal window here